NCT01859078View on ClinicalTrials.gov

A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Baricitinib

Administered orally

DRUG

Digoxin

Administered orally

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01859078 - A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants | Biotech Hunter | Biotech Hunter